Seborrhoeic dermatitis. Seborrhoeic dermatitis
Conditions
Interventions
Intervention 1: Fluconazole 300 mg weekly for four weeks. Intervention 2: Terbinafine 250 mg daily for four weeks.
Treatment - Drugs
Fluconazole 300 mg weekly for four weeks
Terbinafine 250 mg daily for four weeks
Sponsors
Gilan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:Patients with moderate to severe seborrheic dermatitis¸ filling the consent form,no previous treatment history at least 2 weeks before entering the study such as steroids, antifungal agents. Exclusion criteria:Lactation ¸ pregnancy ¸ no pervious diseases such as renal and liver failure, psoriasis, documented human immunodeficiency virus infection and/or sensitivity to fluconazole and terbinafine
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SDASI (Seborrheic dermatitis area severity index). Timepoint: weeks 4 , 6. Method of measurement: Determine severity of disease by examiner according to SDASI.;Itch. Timepoint: 4 weeks later and 6 weeks later. Method of measurement: subjective. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: at first,two and four weeks after treatment. Method of measurement: history,physical exam, laboratory tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamed Monadi Nori MD
Gilan University of Medical Sciencse
Outcome results
None listed